4.7 Article

On the way to find a cure: Purging latent HIV-1 reservoirs

Journal

BIOCHEMICAL PHARMACOLOGY
Volume 146, Issue -, Pages 10-22

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2017.07.001

Keywords

Reservoirs; Latency; Cure; Remission; Shock and kill

Funding

  1. Agence Nationale de Recherches sur le SIDA (ANRS)
  2. Sidaction
  3. Institut Universitaire de France
  4. ANRS (France Recherche Nord & Sud Sida-HIV Hepatites)
  5. Belgian Fund for Scientific Research (FRS-FNRS, Belgium)
  6. Fondation Roi Baudouin
  7. NEAT program
  8. Walloon Region (the Excellence Program Cibles)
  9. International Brachet Stiftung (IBS)
  10. Irish Health Research board (HRB)
  11. Irish Research Council (IRC)
  12. Enterprise Ireland (IE)
  13. European Union's Horizon research and innovation programme [691119 - EU4HIVCURE - H2020-MSCA-RISE2015]

Ask authors/readers for more resources

Introduction of cART in 1996 has drastically increased the life expectancy of people living with HIV-1. However, this treatment has not allowed cure as cessation of cART is associated with a rapid viral rebound. The main barrier to the eradication of the virus is related to the persistence of latent HIV reservoirs. Evidence is now accumulating that purging the HIV-1 reservoir might lead to a cure or a remission. The most studied strategy is the so called shock and kill therapy. This strategy is based on reactivation of dormant viruses from the latently-infected reservoirs (the shock) followed by the eradication of the reservoirs (the kill). This review focuses mainly on the recent advances made in the shock and kill therapy. We believe that a cure or a remission will come from combinatorial approaches i.e. combination of drugs to reactivate the dormant virus from all the reservoirs including the one located in sanctuaries, and combination of strategies boosting the immune system. Alternative strategies based on cell and gene therapy or based in inducing deep latency, which are evoked in this review reinforce the idea that at least a remission is attainable. (C) 2017 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available